Trade Moderna Inc ^MRNA

PBU The Pension Fund of Early Childhood & Youth Educators Takes Position in Merck & Co., Inc. $MRK - Stock Observer

Is Merck & Co. (MRK) One of the Best Cheap Stocks to Buy for Beginners?

Moderna Stock: Is MRNA Outperforming the Health Care Sector?

A Look At Moderna (MRNA) Valuation After Positive Five Year Melanoma Vaccine Trial Data

Moderna (MRNA) Climbs 7.5% Ahead of Next Week's Key Updates

Moderna (NASDAQ:MRNA) Trading 8.1% Higher - Should You Buy?

Heated LNP litigation puts Moderna and Acuitas in the spotlight

Collar Capital Management LLC Increases Stock Holdings in Moderna, Inc. $MRNA - Daily Political

Moderna Inc Stock Live Price, Chart, Analysis, News & Forecast - Buy, Sell & Trade US Equities Today

UBS Lifts Valuation On Moderna, Inc. (MRNA) Ahead of Key Pipeline Catalysts

Moderna to Present at Upcoming Conference in June 2026 | Morningstar

Moderna, Inc. $MRNA Shares Acquired by Lingotto Investment Management LLP

Moderna, Inc. $MRNA Holdings Lowered by Geode Capital Management LLC

AXQ Capital LP Purchases 39,835 Shares of Moderna, Inc. $MRNA

Moderna Inc to Host an Investor Event Transcript

Moderna Spotlights Cancer Vaccine Data Showing 49% Lower Melanoma Recurrence Risk - Zolmax

Moderna (MRNA) and Merck (MRK) Report Promising Results for Cancer Vaccine

Moderna gets $50M investment for Ebola vaccine candidate

Moderna CEO Stephane Bancel on INT trial results: There's duration of efficacy which is exciting

Promising Biotech Stocks To Consider - June 1st

How Investors Are Reacting To Moderna (MRNA) CEPI Funding For Its Ebola Vaccine Program

Moderna and other groups get $60 million to develop Ebola vaccine

Moderna (MRNA) Expands Vaccine Collaboration to Combat Bundibugyo Ebola

IFG Advisory LLC Takes $361,000 Position in Moderna, Inc. $MRNA - Zolmax

Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine

Moderna, Inc. $MRNA Position Reduced by Legal & General Group Plc

CEPI supports Moderna's vaccine against Bundibugyo Ebola virus | BioWorld

Moderna, Inc. $MRNA Shares Sold by Legal & General Group Plc - Daily Political

Perspective Therapeutics (CATX) Gets a Hold from Bank of America Securities

Bank of America Securities Remains a Buy on Aktis Oncology, Inc. (AKTS)

Bank of America Securities Remains a Hold on Candel Therapeutics (CADL)

Bank of America Securities Sticks to Their Buy Rating for HUTCHMED (HCM)

Moderna (MRNA) Gets a Sell from Bank of America Securities

Bank of America Securities Sticks to Their Buy Rating for Immatics (IMTX)

Biotech Stocks To Consider - May 27th - Daily Political

Assessing Moderna (MRNA) Valuation After A Strong Yearly Rally And Ongoing Losses

Moderna and Merck's Cancer Combo Reduces Melanoma Spread Risk by 59% Over Five Years, ETPharma

Biotech Stocks To Research - May 24th - Zolmax

Biotech Stocks To Watch Now - May 23rd - Daily Political

North Dakota State Investment Board Invests $359,000 in Moderna, Inc. $MRNA - Daily Political

Insider Selling: Moderna (NASDAQ:MRNA) Director Sells $433,878.92 in Stock

Moderna Inc. (MRNA) - Insider Monkey

Moderna, Merck cancer combo cuts melanoma spread risk at five years

FDA to Hold Review Meeting for Moderna's Flu Vaccine | Morningstar

Moderna's (MRNA) Flu Vaccine Set for FDA Advisory Panel Review

FDA Plans Rare Advisory Hearing to Debate Moderna's Flu Shot

Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now

Promising Biotech Stocks To Consider - May 21st - Stock Observer

Immunovant Q4 Earnings Call Highlights - Daily Political

Moderna Inc at RBC Capital Markets Global Healthcare Conference Transcript

Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Warren Buffett, Viking Global, Darsana Capital Partners, Caxton Associates, Balyasny Asset Management, D1 Capital Partners, Republic Services Inc (RSG), Moderna Inc (MRNA), and More

Best Biotech Stocks To Add to Your Watchlist - May 18th

Insider Selling: Moderna (NASDAQ:MRNA) President Sells 53,336 Shares of Stock - Daily Political

Is Moderna (MRNA) Quietly Recasting Its mRNA Platform From Pandemic Play to Broad Vaccine Franchise?

Biotech Stocks To Research - May 17th - Stock Observer

Salesforce (CRM) Valuation Check As New AI Deals And Air Force Contract Lift Market Interest

Best Biotech Stocks To Keep An Eye On - May 15th - Daily Political

Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

Top Biotech Stocks To Consider - May 14th - Daily Political

Best Biotech Stocks To Keep An Eye On - May 15th - Stock Observer

Israel to offer non-mRNA coronavirus vaccine

BMJ Senior Editor: COVID vaccines more likely to put you in hospital than keep you out

Top Biotech Stocks To Consider - May 14th - Zolmax

Salesforce (CRM), Moderna Partner to Unify Global Operations via Agentforce Life Sciences

Want To Invest With Impact? Here Are 4 Options To Consider

3 Cash-Heavy Stocks with Warning Signs

Moderna's TIME Ranking And Combo Vaccine Approval Reshape Growth Question

Staged claims and Israeli hoaxes: Debunking viral conspiracy theories about hantavirus

Best Biotech Stocks To Consider - May 13th - Stock Observer

Still 'many steps to do' in creating a hantavirus vaccine, experts say

Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update

No cure, no approved vaccine, no antiviral: Why the Hantavirus threat is raising alarm again | Explained

Hantavirus fears put Moderna vaccine efforts in focus

Moderna Hantavirus Program Draws New Focus As Shares Outpace Targets

5 Insightful Analyst Questions From Moderna's Q1 Earnings Call

Health Care Down as Vaccine Bets Stall - Health Care Roundup | Morningstar

Moderna stock whipsaws as investors monitor hantavirus outbreak

Moderna Stock Is Surging on Hantavirus Threats. Its Chart Offers a Harsh Dose of Reality.

New Moderna Short Target After Hantavirus Vaccine News

Here's how much Moderna's stock has rallied off renewed focus on hantavirus research | Morningstar

Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone?

Why Moderna Inc (MRNA) May Struggle to Outperform: A Look at Future Challenges

Moderna shares jump as it reveals it has been researching vaccines against hantaviruses

Moderna Extends Rally After Two More Cruise Ship Passengers Test Positive For Hantavirus

Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging. - AOL

Moderna stock surges 22% in 2 days as investors monitor hantavirus outbreak

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Premarket Winners: Moderna (MRNA), Intel (INTC), and Micron (MU) Rally on Monday

Moderna stock extends gains on hantavirus research

Hantavirus cases spark surge in pharma, biotech stocks - here's why